Fibroblast-Secreted Phosphoprotein 1 Mediates Extracellular Matrix Deposition and Inhibits Smooth Muscle Cell Contractility in Marfan Syndrome Aortic Aneurysm

J Cardiovasc Transl Res. 2022 Oct;15(5):959-970. doi: 10.1007/s12265-022-10239-8. Epub 2022 Apr 12.

Abstract

Fibrillin 1 (Fbn1) mutation causes Marfan syndrome (MFS) with thoracic aortic aneurysm (TAA) as the main complication. The mechanisms for extracellular matrix (ECM) homeostasis disruption in MFS TAA are unclear. Here, we found ECM-related gene secreted phosphoprotein 1 (Spp1) increased in Fbn1C1041G/+ mice using transcriptome sequencing and a distinct fibroblast subcluster with Spp1 as the strongest marker was identified with analysis of the MFS mouse aortic single-cell sequencing dataset. Immunostaining confirmed elevated Spp1 in adventitial fibroblasts, and Spp1 might regulate fibroblast and smooth muscle cell (SMC) communication primarily through Itga8/Itgb1. Then, we observed Spp1 reduced contractile genes Acta2 and Tagln expression in SMCs and increased collagen expression in fibroblasts, which might contribute to TAA development. Finally, we also found elevated SPP1 plasma level was associated with an increased risk of TAA in patients. Therefore, SPP1 may serve as a biomarker and therapeutic target for TAA.

Keywords: Aortic aneurysm; Extracellular matrix; Fibroblast; Marfan syndrome; Secreted phosphoprotein 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aortic Aneurysm* / genetics
  • Aortic Aneurysm, Thoracic* / genetics
  • Extracellular Matrix / metabolism
  • Fibroblasts / metabolism
  • Marfan Syndrome* / complications
  • Marfan Syndrome* / genetics
  • Marfan Syndrome* / metabolism
  • Mice
  • Muscle, Smooth, Vascular / metabolism
  • Myocytes, Smooth Muscle / metabolism
  • Osteopontin / genetics
  • Osteopontin / metabolism

Substances

  • Osteopontin